Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies

Robert Lentz, Al B Benson III, Sheetal Mehta Kircher*

*Corresponding author for this work

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Financial toxicity is the adverse impact of a cancer diagnosis on a patient’s financial well-being resulting from direct or indirect costs. Potential consequences of financial toxicity include material loss, psychological distress, and/or maladaptive coping strategies. This review will summarize the prevalence, causes, and consequences of financial toxicity, with an emphasis on strategies to anticipate and reduce its burden. Improvement will require multilevel, coordinated efforts between stakeholders including patients, providers, health systems, payers, manufacturers, and policymakers.

Original languageEnglish (US)
Pages (from-to)85-92
Number of pages8
JournalJournal of Surgical Oncology
Volume120
Issue number1
DOIs
StatePublished - Jul 1 2019

Fingerprint

Neoplasms
Psychology
Costs and Cost Analysis
Health

Keywords

  • cancer
  • financial burden
  • financial distress
  • financial hardship
  • financial toxicity

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

@article{841f5a29f8074f7086543cd0188779cf,
title = "Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies",
abstract = "Financial toxicity is the adverse impact of a cancer diagnosis on a patient’s financial well-being resulting from direct or indirect costs. Potential consequences of financial toxicity include material loss, psychological distress, and/or maladaptive coping strategies. This review will summarize the prevalence, causes, and consequences of financial toxicity, with an emphasis on strategies to anticipate and reduce its burden. Improvement will require multilevel, coordinated efforts between stakeholders including patients, providers, health systems, payers, manufacturers, and policymakers.",
keywords = "cancer, financial burden, financial distress, financial hardship, financial toxicity",
author = "Robert Lentz and {Benson III}, {Al B} and Kircher, {Sheetal Mehta}",
year = "2019",
month = "7",
day = "1",
doi = "10.1002/jso.25374",
language = "English (US)",
volume = "120",
pages = "85--92",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "1",

}

Financial toxicity in cancer care : Prevalence, causes, consequences, and reduction strategies. / Lentz, Robert; Benson III, Al B; Kircher, Sheetal Mehta.

In: Journal of Surgical Oncology, Vol. 120, No. 1, 01.07.2019, p. 85-92.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Financial toxicity in cancer care

T2 - Prevalence, causes, consequences, and reduction strategies

AU - Lentz, Robert

AU - Benson III, Al B

AU - Kircher, Sheetal Mehta

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Financial toxicity is the adverse impact of a cancer diagnosis on a patient’s financial well-being resulting from direct or indirect costs. Potential consequences of financial toxicity include material loss, psychological distress, and/or maladaptive coping strategies. This review will summarize the prevalence, causes, and consequences of financial toxicity, with an emphasis on strategies to anticipate and reduce its burden. Improvement will require multilevel, coordinated efforts between stakeholders including patients, providers, health systems, payers, manufacturers, and policymakers.

AB - Financial toxicity is the adverse impact of a cancer diagnosis on a patient’s financial well-being resulting from direct or indirect costs. Potential consequences of financial toxicity include material loss, psychological distress, and/or maladaptive coping strategies. This review will summarize the prevalence, causes, and consequences of financial toxicity, with an emphasis on strategies to anticipate and reduce its burden. Improvement will require multilevel, coordinated efforts between stakeholders including patients, providers, health systems, payers, manufacturers, and policymakers.

KW - cancer

KW - financial burden

KW - financial distress

KW - financial hardship

KW - financial toxicity

UR - http://www.scopus.com/inward/record.url?scp=85060163595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060163595&partnerID=8YFLogxK

U2 - 10.1002/jso.25374

DO - 10.1002/jso.25374

M3 - Review article

C2 - 30650186

AN - SCOPUS:85060163595

VL - 120

SP - 85

EP - 92

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 1

ER -